Lucira Health to Announce Fourth Quarter 2021 Financial Results
Lucira Health, Inc. (LHDX) will announce its fourth quarter 2021 financial results on March 10, 2022.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Lucira Health, Inc. (LHDX) will announce its fourth quarter 2021 financial results on March 10, 2022. A conference call and webcast will follow at 1:30 p.m. PT / 4:30 p.m. ET to discuss the results and provide corporate updates. Lucira Health specializes in innovative infectious disease test kits, including the Lucira Check-It COVID-19 Test Kit, which provides results in approximately 30 minutes. The company aims to deliver lab-quality testing in a compact, user-friendly format.
Positive
- Announcement of fourth quarter 2021 financial results indicates potential engagement with investors.
- Lucira's rapid COVID-19 testing kits are designed for quick results, enhancing their market offering.
Negative
- None.
Details
News Market Reaction – LHDX
The recorded move for LHDX in the trading session of this news was -3.31%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
EMERYVILLE, Calif., Feb. 28, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (“Lucira Health” or “Lucira”) (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today announced that the company will report fourth quarter 2021 financial results on, Thursday, March 10, 2022. Lucira’s management will host a conference call and webcast at 1:30 p.m. PT / 4:30 p.m. ET that day to discuss the financial results and provide a corporate update.
Conference Call and Webcast Details
The conference call can be accessed by dialing (833) 562-0151 for participants in the U.S. or Canada and (661) 567-1232 for international callers, using conference ID 9897752. A live and archived webcast of the event can be accessed through the following link ir.lucirahealth.com.
About Lucira Health, Inc.
Lucira is a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits. Lucira's testing platform produces lab quality molecular testing in a single-use, consumer-friendly, palm-size test kit powered by two AA batteries. Lucira designed its test kits to provide accurate, reliable, and on-the-spot molecular test results anywhere and at any time. The Lucira™ Check-It COVID-19 Test Kit (OTC) and Lucira™ COVID-19 All-In-One Test Kit (Rx) are designed to provide a clinically relevant COVID-19 result within 30 minutes from sample collection. For more information, visit www.lucirahealth.com.
Investor Contact
Greg Chodaczek
Investorrelations@lucirahealth.com
332-895-3230
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.